Effectiveness and acceptability of metformin in preventing the onset of type 2 diabetes after gestational diabetes in postnatal women: a protocol for a randomised, placebo-controlled, double-blind feasibility trial — Optimising health outcomes with Metformin to prevent diAbetes After pregnancy (OMAhA)

INTRODUCTION: Up to half of all women diagnosed with gestational diabetes mellitus develop type 2 diabetes within 5 years after delivery. Metformin is effective in preventing type 2 diabetes in high-risk non-pregnant individuals, but its effect when commenced in the postnatal period is not known. We...

Descripción completa

Detalles Bibliográficos
Autores principales: Amaefule, Chiamaka Esther, Bolou, Angeliki, Drymoussi, Zoe, Gonzalez Carreras, Francisco Jose, Pardo Llorente, Maria del Carmen, Lanz, Doris, Dodds, Julie, Sweeney, Lorna, Pizzo, Elena, D’Amico, Maria, Thomas, Amy, Heighway, James, Daru, Jahnavi, Sobhy, Soha, Robson, John, Sanghi, Anita, Zamora, Javier, Harden, Angela, Hitman, Graham, Khan, Khalid, Pérez, Teresa, Huda, Mohammed SB, Thangaratinam, Shakila
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Obstetrics and Gynaecology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239519/
https://www.ncbi.nlm.nih.gov/pubmed/32423937
http://dx.doi.org/10.1136/bmjopen-2019-036198

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239519/
https://www.ncbi.nlm.nih.gov/pubmed/32423937
http://dx.doi.org/10.1136/bmjopen-2019-036198

Ejemplares similares